Navigation Links
Actinium Pharmaceuticals Clinical Results Featured at a United Nations Forum
Date:7/9/2013

NEW YORK, July 9, 2013 /PRNewswire/ -- Actinium Pharmaceuticals Inc. (OTCQB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for treatment of advanced cancers, announced that the Actinium Pharmaceuticals' clinical programs and platform technology were presented in Vienna, Austria, at a technical meeting at the International Atomic Energy Agency (IAEA). The presentation was delivered by Dr. David Scheinberg, Interim Director of the Sloan-Kettering Institute, research division of the Memorial Sloan-Kettering Cancer Center.

"There is increasing interest in the uses of alpha particle therapy around the world," said Dr. Scheinberg. "We now see scientists, clinicians, isotope manufacturers, government agencies and commercial companies collaborating to enable therapeutic advances of these agents against cancer." 

Dr. Scheinberg's presentation focused on Actinium Pharmaceuticals' drug candidates Actimab-A and Bismab for acute myeloid leukemia as well as applications of alpha immunotherapy in treatment of solid cancers. The IAEA meeting at the United Nations headquarters in Vienna, Austria, was a closed workshop entitled "Alpha Emitting Radionuclides and Radiopharmaceuticals for Therapy".

About Actimab - A
Actimab-A is a drug candidate construct made using Actinium Pharmaceuticals' proprietary patented technology for arming monoclonal antibodies with alpha emitters actinium-225 and bismuth-213.  Antibodies are used as high precision delivery systems that bring powerful alpha emitters into or immediately next to targeted cancer cells. Actimab-A consists of the Lintuzumab monoclonal antibody and actinium-225.

Actinium-225 decays by giving off high-energy alpha particles, which kill cancer cells. When actinium decays, it produces a series of daughter atoms, each of which giv
'/>"/>

SOURCE Actinium Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants
2. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
3. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
4. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
5. Actinium Pharmaceuticals, Inc. To Present at the 15th Annual BIO CEO Investor Conference
6. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
7. University of Pennsylvania joins Actinium Pharmaceuticals Multicenter Actimab-A Trial
8. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
9. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
10. Actinium Pharmaceuticals Announces New Round of Financing
11. Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... 20, 2014   Easy Breathe , the fastest growing online ... Easy Blog " - has received more than 4.5 million unique ... "We are thrilled that so many people are finding our blog ... Easy Breathe. "We,re committed to making sleep apnea more widely known ... informed about sleep apnea news , troubleshooting advice , ...
(Date:8/20/2014)... , August 20, 2014 ... subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces ... of a novel clinical development candidate, GBR 1302, ... and developed by the Glenmark Biologics Research Centre ... . GBR 1302 is based on Glenmark,s innovative ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3
... SAN DIEGO, May 16, 2011 Cardium Therapeutics ... its financial results for the first quarter ended ... ) (Logo:   http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ... quarter 2011 financial results, Cardium reported on the ...
... R.I., May 16, 2011 Obtaining prior authorization for ... and pharmacists that currently requires phone calls, faxes and ... they do not provide both a real-time solution and ... health record (EHR) tools.  Recognizing this gap in the ...
Cached Medicine Technology:Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 2Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 3Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 4Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 5Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 6Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 7Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 8Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 9Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones 10CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 2CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 3
(Date:8/20/2014)... Verndale is pleased to announce their recent ... list ranking the fastest-growing private companies in America. The ... yearly percentage revenue growth over a three-year period. For ... 5000 list where it ranked number 2,855. , As ... a wide range of digital marketing services including core ...
(Date:8/20/2014)... North Carolina (PRWEB) August 20, 2014 ... , findings from a University College London (UCL) study ... disagreed on what method of brushing teeth was the ... found that six different tooth-brushing techniques were frequently recommended, ... the Charlotte Center for Cosmetic Dentistry, experienced cosmetic ...
(Date:8/20/2014)... 20, 2014 Oxnard dentist ... the Anacapa Dental Art Institute, is presenting at the ... will be speaking on All-on-4 dental implants ... Graft Less Solutions” at 12:40 p.m. Sept. 20 at ... British Columbia, Canada. , “The All-on-4 procedure gives patients ...
(Date:8/20/2014)... 20, 2014 Biosimilars, which are ... approved through an abbreviated process, could reap billions ... Atlantic Information Services, Inc.’s (AIS) Specialty Pharmacy News ... including the Food and Drug Administration’s (FDA) recent ... towards approval. , Drugmaker Sandoz said July 24 ...
(Date:8/20/2014)... 20, 2014 No matter how “lonely” a ... a steady set of friends to be always there for ... to the concept of making new friends during adulthood ... ranging from taking care of one’s family to a near-slavish ... to a new person just is not the same as ...
Breaking Medicine News(10 mins):Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2
... the psychiatrist Dr Charles Reynolds at the University of Pittsburgh ... , The study’s main aim was to analyze ... elderly people. It is one of the longest studies ... prescribe antidepressants for longer periods, perhaps even for life, in ...
... Department of New South Wales has conducted a study which ... the user's physical health// . , It is ... Cannabis abuse can lead to cardiovascular, respiratory and immune system ... slow brain development at a young age. New South Wales ...
... Yale shed new light on the mechanism of nerve ... "motor" protein, myosin-II, according to an //article in the ... develop or attempt to recover after damage, they extend ... sensors. Growth cones use the information they gather to ...
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... overcrowding of farm owners in local veterinary centres has created much ... Nadub //. The deadly avian influenza virus outbreak in India was ... 20 chickens dropped dead Saturday in Manakkad area of Salem district, ... for tests. ,Tamil Nadu has been on high alert ...
... pain by taking Oxycontin, a prescription painkiller. Later on for ... cheaper option. // Michaud, now 18 years is one ... prescription drugs. Teenagers are increasingly experimenting with legal drugs like ... from medicine cabinets. , Health officials say that ...
Cached Medicine News:Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:A New Focus For The Mechanism Of Nerve Growth 2Health News:Romantic and discreet trends in lingerie 2Health News:New Generation Teenagers Addiction to Prescription Drugs 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: